Human factor XIII as a normalization control for immunoassays

Patent metadata

Field	Value
Publication number	US-10191039-B2
Application number	US-201715710334-A
Country	US
Kind code	B2
Filing date	Sep 20, 2017
Priority date	Jun 22, 2012
Publication date	Jan 29, 2019
Grant date	Jan 29, 2019

Abstract

The present disclosure provides compositions and methods that are useful for normalizing the amount of signal detected in an assay, such as an immunoassay. The compositions and methods are useful for improving the accuracy of immunoassays, such as immunoassays that detect whether a subject is infected with a retrovirus such as HIV.

First claim

What is claimed is:

1. A kit for correcting for variations in sample processing and/or biological matrix effects when performing biological assays, said kit comprising human blood coagulation Factor XIII (hFXIII) immobilized on a solid support, and
a plurality of solid supports having binding members immobilize thereon that bind an analyte in a sample, wherein the plurality of solid supports are divided into subpopulations that are differentiable from each other by a differentiation parameter comprising a characteristic that is independent of the binding members immobilized on the solid supports, and the binding members immobilized on each subpopulation are capable of binding to one analyte in the sample,
wherein the solid support and/or the plurality of solid supports is selected from the wall or floor of an assay vessel, a dipstick, particles inside or suspended in an assay vessel, a bead, a magnetic bead, or a microparticle formed of a polymeric material.

2. The kit of claim 1 , wherein hFXIII does not bind an analyte from a biological sample.

3. The kit of claim 1 , further comprising an antibody to human Factor XIII immobilized on a solid support.

4. The kit of claim 1 , further comprising tetramethylcadaverine rhodamine (TMRC) immobilized on a solid support.

5. The kit of claim 1 , wherein the solid support and/or the plurality of solid supports is a bead or magnetic bead.

6. A composition for correcting for variations in sample processing and/or biological matrix effects when performing biological assays, said composition comprising hFXIII coupled to a solid support, and
a plurality of solid supports having binding members immobilize thereon that bind an analyte in a sample, wherein the plurality of solid supports are divided into subpopulations that are differentiable from each other by a differentiation parameter comprising a characteristic that is independent of the binding members immobilized on the solid supports, and the binding members immobilized on each subpopulation are capable of binding to one analyte in the sample,
wherein the solid support and/or the plurality of solid supports is selected from the wall or floor of an assay vessel, a dipstick, particles suspended in an assay vessel, a bead, a magnetic bead, or a microparticle formed of a polymeric material.

7. The composition of claim 6 , wherein hFXIII does not bind an analyte from a biological sample.

8. The composition of claim 6 , further comprising an antibody to human Factor XIII immobilized on a solid support.

9. The composition of claim 6 , further comprising tetramethylcadaverine rhodamine (TMRC) immobilized on a solid support.

10. The composition of claim 6 , wherein the solid support and/or the plurality of solid supports is a bead or magnetic bead.

11. The kit of claim 1 , wherein the characteristic is selected from particle size, particle diameter, particle composition, light scatter, absorbance, number of particles, fluorescent dyes or colored dyes that impart different emission spectra and/or scattering characteristics to the solid supports, or from different concentrations of one or more fluorescent dyes.

12. The composition of claim 6 , wherein the characteristic is selected from particle size, particle diameter, particle composition, light scatter, absorbance, number of particles, fluorescent dyes or colored dyes that impart different emission spectra and/or scattering characteristics to the solid supports, or from different concentrations of one or more fluorescent dyes.

Assignees

• Bio Rad Laboratories

Inventors

• King David
• Link William F
• Del Rosario Renato
• Leos Michael

Classifications

• C12N9/1044

  Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title

• G01N33/56988

  HIV or HTLV · CPC title

• G01N33/543 Primary

  with an insoluble carrier for immobilising immunochemicals · CPC title

• G01N33/54393 Primary

  Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

• C12Y203/02013

  Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title